10-Q: Healthcare Integrated Technologies Reports Q3 2024 Results, Revenue Growth Offset by Ongoing Losses

Healthcare Integrated Technologies, Inc. reported a net loss of $215,218 for the three months ended April 30, 2024, despite recognizing $60,283 in revenue.

Summary

• Healthcare Integrated Technologies, Inc. reported a net loss of $215,218 for the three months ended April 30, 2024, and a net loss of $598,881 for the nine months ended April 30, 2024.
• The company recognized $60,283 in revenue for the three months ended April 30, 2024, and $82,052 for the nine months ended April 30, 2024, primarily from a service agreement that concluded on April 1, 2024.
• Operating expenses totaled $262,140 for the three months and $641,523 for the nine months ended April 30, 2024, with significant costs in selling, general, and administrative expenses, stock-based compensation, and amortization of intangibles.
• The company's working capital deficiency was $1,537,893 as of April 30, 2024, compared to $1,535,300 as of July 31, 2023.
• The company has a history of losses and negative cash flow, raising substantial doubt about its ability to continue as a going concern.
• The company is relying on private sales of common stock and short-term loans from related parties to fund operations.

Sentiment

Score: 3

Explanation: The document reveals significant financial challenges, including substantial losses, a large working capital deficit, and a going concern qualification. While there are some positive developments, such as revenue generation and strategic alliances, the overall sentiment is negative due to the company's precarious financial position and reliance on short-term funding.

Positives

• The company successfully generated revenue of $60,283 for the three months ended April 30, 2024, and $82,052 for the nine months ended April 30, 2024.
• The company has formed a strategic alliance with Signature HealthCARE to pilot test and deploy its AI-based solutions.
• The company secured a $266,000 contract with Signature to install its SafeFace software in 19 facilities.
• The company has introduced and is pilot testing two new products, SafeFace and SafeGuard.

Negatives

• The company reported a net loss of $215,218 for the three months ended April 30, 2024, and a net loss of $598,881 for the nine months ended April 30, 2024.
• The company has a significant working capital deficiency of $1,537,893 as of April 30, 2024.
• The company's auditors have raised substantial doubt about its ability to continue as a going concern.
• The company is currently relying on short-term loans from related parties and private sales of common stock to fund operations.
• The company has $175,000 in 5% convertible promissory notes and a $50,000 note payable to Acorn Management Partners, LLC in default.
• The company was unable to move forward with the acquisition of Glass 8 Holdings LLC due to due diligence issues.

Risks

• The company's ability to continue as a going concern is dependent on securing adequate capital and generating revenue.
• The company faces risks related to competition, market acceptance of its products, and changes in regulations.
• The company is involved in a legal proceeding related to a loan guarantee of a related entity.
• The company's reliance on related party loans and private equity sales may not be sustainable.
• The company's internal controls over financial reporting are not effective.

Future Outlook

The company intends to finance future activities and working capital needs through the sale of private and/or public equity securities and other traditional financing sources. The company is also focused on developing new product lines and expanding its market reach.

Management Comments

• Our management team is focused on maintaining financial flexibility and assembling the right complement of personnel and outside consultants required to successfully execute our mission.
• We continue to utilize funds raised from the private sales of our common stock, issuance of debt, and short-term advances from related parties to provide cash for our operations.
• We are likely to continue using short-term loans from management to meet our short-term funding needs.

Industry Context

The company operates in the healthcare technology sector, which is experiencing growth due to increasing demand for remote patient monitoring and AI-based solutions. The company's focus on continuing care, home care, and professional healthcare spaces aligns with current industry trends.

Comparison to Industry Standards

• The company's revenue of $82,052 for the nine months ended April 30, 2024, is significantly lower than established companies in the healthcare technology sector, such as Teladoc Health or Dexcom, which report revenues in the hundreds of millions or billions of dollars.
• The company's net loss of $598,881 for the nine months ended April 30, 2024, is not unusual for early-stage technology companies, but the magnitude of the loss relative to revenue is concerning.
• The company's reliance on related party loans and private equity sales is not typical for established companies in the sector, which often have access to more traditional financing options.
• The company's working capital deficiency of $1,537,893 indicates a significant liquidity risk, which is not typical for companies with established revenue streams.

Management Changes

Legal Proceedings

• Apex Funding Source, LLC filed a lawsuit against the company's subsidiaries, Grasshopper Staffing, Inc. and Indeliving Holdings, Inc., for an alleged guarantee of a loan to Blue Earth Resources, Inc.
• The lawsuit also names Scott M. Boruff and Platinum Equity Advisors, LLC as defendants for their alleged guaranty of the BERI loan.
• The Lender filed a motion seeking partial summary judgment against BERI and Scott M. Boruff for $4,705,900 plus attorneys fees.

Related Party Transactions

• The company has significant related party transactions, including loans from Platinum Equity Advisors, LLC, a company owned by the spouse of the CEO.
• The company has a Non-Employee Chief Executive Officer Engagement Agreement with Platinum Equity Advisors, LLC.
• The company has a Non-Employee Chief Strategy Officer Engagement Agreement with Ryan Hillis.
• The company owes related parties $201,790 for accounts payable and accrued expenses as of April 30, 2024.
• The company owes Platinum Equity $125,886 for amounts related to the Contract CEO Agreement as of April 30, 2024.

Stakeholder Impact

• Shareholders face significant risk due to the company's financial instability and going concern qualification.
• Employees may be impacted by potential cost-cutting measures or restructuring.
• Customers may be concerned about the company's ability to deliver on its contracts and provide ongoing support.
• Creditors face the risk of non-payment due to the company's financial difficulties.

Next Steps

• The company will continue to evaluate its new products, SafeFace and SafeGuard.
• The company will continue to pilot test and deploy its AI-based solutions across multiple Signature senior living facilities.
• The company will continue to seek additional funding through private and/or public equity securities.
• The company will continue to negotiate amendments to the notes in default.

Key Dates

Keywords

healthcare technology, AI, fall detection, remote monitoring, software, financial results, going concern, SafeSpace, SafeFace, SafeGuard